Chief Executive Officer
BioDelivery Sciences is a specialty pharmaceutical company focusing on pain management and addiction medicine.
Executive leader with over thirty-five (35) years of pharmaceutical industry experience including 13 years as CEO of a public company that went from a preclinical stage to a fully integrated commercial enterprise following the FDA approval of three products under his leadership. Prior to this fourteen (14) years in research and development (ethical and over-the-counter switch products) in the areas of gastrointestinal, cardiovascular, respiratory, pain and addiction; 6 years in sales and marketing including the management of global sales and marketing for a contract research organization and as head of new product marketing for a major pharmaceutical company. Also served on five public company boards during this period. - 30 years of Pharmaceutical R&D and Commercial Experience - Public Company Management - Start up Company Mangement - Board of Directors Involvement - Capital Raising behind venture and public companies - Merger & Aquisition and Product Licensing Transactions - Assement of Product Portfolios - Clinical Development & Regulatory Strategy Specialties: Start-Up Companies Capital Raising Drug Development Business Development Asset Valuation